Product Categories
| Country: | China |
|---|---|
| Tel: | 0571-88211921 |
| Mobile: | 13735575465 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| c(RGDFK(Biotin)) | C12H16O3 | 56718-70-8 | Details |
| E-[c(RGDyK)2] | Details |
| cyclo(RGDfK{Mpa}) | Details |
| cyclo(RGDyK-COCH2CH2SH) | Details |
| c(RGDyV) | Details |
| Cyclo（RGDfK（6-Azido-hexanoic acid）） | Details |
| ISO-ASP5] Oxytocin | Details |
| [Asp5] oxytocin | C13H9NOS | 3159-07-7 | Details |
| SN50 | C129H230N36O29S | 213546-53-3 | Details |
| RRRRRRRR | Details |
| MMP-3 Substrate | C78H110N22O20 | 158584-09-9 | Details |
| Mca-AVLQSGFR-Lys(Dnp)-Lys-NH2 | Details |
| Bay 55-9837 | C167H270N52O46 | 463930-25-8 | Details |
| Pramlintide | Details |
| β-Amyloid （15-21） | C??H??N?O? | Details |
| RADA16 | Details |
| Glucagon Hydrochloride | C6H9ClO5 | 11140-85-5 | Details |
| Lys-Bradykinin | C56H85N17O12 | 342-10-9 | Details |
| NeuropeptideSF(mouse,rat) | C40H65N13O10 | 230960-31-3 | Details |
| Mca-Pro-Leu-OH | C23H28N2O7 | 140430-55-3 | Details |
| EGF Receptor Substrate 2 Phospho-Tyr5 | C??H??N??O?? | Details |
| Senktide | C40H55N7O11S | 106128-89-6 | Details |
| Super-TDU | C237H370N66O69S | 1599441-71-0 | Details |
| Ghrelin | Details |
| GRGDSPC | C25H42N10O11S | 91575-26-7 | Details |
| [Glu4] oxytocin | C40H44N6O2S2 | 1371638-05-9 | Details |
| β-Defensin 2 (human)/β-Defensin 4A (human), Skin-antimicrobial peptide 1 (human) | Details |
| KKI-7 | C36H58N10O8 | 113584-01-3 | Details |
| Lyn peptide inhibitor | C115H184N30O24 | 222018-18-0 | Details |
| EGFRvIIIpeptidePEPvIII | C70H111N19O24S | 129112-17-0 | Details |
| Murepavadin | C73H112N22O16 | 944252-63-5 | Details |
| T7 Tag Peptide | C??H??N??O??S? | Details |
| FA-GLA | C18H25N3O6 | 56186-50-6 | Details |
| Ghrelin (human) | C149H249N47O42 | 304853-26-7 | Details |
| myristoyl tripeptide 31 | Details |
| Cardiotoxin Analog (CTX) IV (6-12) (TFA) | C48H70N10O7 | Details |
| H-γ-Glu-Abu-Gly-OH | Details |
| H-Gly-His-Gly-OH | C10H15N5O4 | 7758-33-0 | Details |
| Davalintide | C152H248N50O49S2 | 863919-85-1 | Details |
| SHU 9119 | C54H71N15O9 | 168482-23-3 | Details |
| Saralasin | C42H65N13O10 | 34273-10-4 | Details |
| Angiotensin (1-7) | C41H62N12O11 | 51833-78-4 | Details |
| PAMP-12(human,porcine) | C77H119N25O14 | 196305-05-2 | Details |
| α-Conotoxin MII | C67H103N23O22S4 | 175735-93-0 | Details |
| α-Conotoxin AuIB | C65H89N17O21S4 | 216299-21-7 | Details |
| c(RGDfC) | C24H34N8O7S | 862772-11-0 | Details |
| c(RGDfE) | C26H36N8O9 | 756500-22-8 | Details |
| Oxytocic acid | C21H27N3O3S | 848814-27-7 | Details |
| c(RGDyK) | C27H41N9O8 | 217099-14-4 | Details |
| c(RGDyE) | Details |
| FALGPA | C23H32N4O7 | 78832-65-2 | Details |
| Somatostatin | C76H104N18O19S2 | 38916-34-6 | Details |
| Dalargin | C35H51N9O8 | 81733-79-1 | Details |
| FOXO4-DRI | 2460055-10-9 | Details |
| c(RGDfK) | C27H41N9O7 | 161552-03-0 | Details |
| [Ala17]-MCH | C97H155N29O26S4 | 359784-84-2 | Details |
| LF 11 | C69H112N26O14 | 832729-13-2 | Details |
| N-Acetyl CholecystokininCCK | C38H50N8O13S3 | 89911-65-9 | Details |
| 2-Furoyl-LIGRLO-amide | C36H63N11O8 | 729589-58-6 | Details |
| Dabcyl-Gaba-SQNYPIVQ-Edans | C73H97N17O18S | 127134-13-8 | Details |
| H-ARG-ARG-NH2 3 HCL | C12H30Cl3N9O2 | 114736-11-7 | Details |
| PKA Inhibitor Fragment (6-22) amide | C80H130N28O24 | 121932-06-7 | Details |
| c(RGDfV) | C26H38N8O7 | 137813-35-5 | Details |
| E-[c(RGDfK)2] | C57H83N19O16 | 2377091-64-8 | Details |
| S Tag Peptide | C73H117N23O25S | 7429-70-1 | Details |
| cyclo(RGDfK-COCH2SH) | Details |
| GLU4ASP5] oxytocin | Details |
| c(RGDfK(Biotin-PEG-PEG)) | Details |
| DOTA-RGDfK dimer | C75H113N23O23 | 250612-06-7 | Details |
| TP508 | C97H146N28O36S | 121341-81-9 | Details |
| d[Cha4]-AVP | C50H71N13O11S2 | 500170-27-4 | Details |
| Cholecystokinin-33 (human) | C29H30N2O6 | 96827-04-2 | Details |
| Angiotensin II (1-4), human | C24H37N7O8 | 52580-29-7 | Details |
| Product Total： Product Page： | ||||
| 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 | ||||